Insider · CIK 0002012430
Sandoval David I.
Reports to the SEC for 2 companies · MONTREAL
Transactions
6
Companies
2
Filings
4
CIK
0002012430
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-03-18 | MXCTMAXCYTE, INC.S Sale | −$1,122.293 |
| 2025-03-14 | MXCTMAXCYTE, INC.A Award | — |
| 2025-03-14 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)A Award | — |
| 2025-01-13 | MXCTMAXCYTE, INC.S Sale | −$20.3K |
| 2024-03-15 | MXCTMAXCYTE, INC.A Award | — |
| 2024-03-15 | MXCTMAXCYTE, INC. · Employee Stock Option (right to buy)A Award | — |
Recent filings
- 4Sandoval David I.0000905148-25-000985SEC(opens sec.gov)
- 4Sandoval David I.0000905148-25-000963SEC(opens sec.gov)
- 4Sandoval David I.0000905148-25-000092SEC(opens sec.gov)
- 4Sandoval David I.0001415889-24-008638SEC(opens sec.gov)
Companies
Address
C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTREAL, H4M 2X6